TCL Archive DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate October 1, 1976
TCL Archive Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal September 3, 2010
TCL Archive In Brief: PHS Established Two Scientific Integrity Offices; Workshop On Ethical Issues Planned August 18, 1989